Continuing Medical Education For HCPs
Staying updated with the latest advancements in diabetes health is crucial for healthcare professionals. Our Continuing Medical Education (CME) resources offer in-depth insights into the evolving landscape of diabetes management. Explore a range of educational materials designed to empower medical professionals with the knowledge needed to offer the best possible care to patients dealing with diabetes. Stay informed about the latest treatment approaches, research findings, and innovative strategies for diabetes care.
Sponsored By
Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
Trial Title A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS), together with a lifestyle modification program, compared to a ...
Condition: Type 2 Diabetes
Models of Nutrition From Continuous Glucose Monitors
With this study, researchers want to conduct ambulatory studies in which people (healthy, with T2D, or at-risk of T2D) will consume a variety of pre-set and conventional meals in free-living condition ...
Condition: Diabetes Mellitus, Type 2
A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program
A pilot study titled "A Virtual Cardiometabolic Health Program for African Immigrants (The Afro-DPP Program) will be conducted to address the cardiometabolic of community-dwelling African immigra ...
Condition: Diabetes Mellitus
Development and validation of a predictive model for prolonged length of stay in elderly type 2 diabetes mellitus patients combined with cerebral infarction
Background: This study aimed to identify the predictive factors for prolonged length of stay (LOS) in elderly type 2 diabetes mellitus (T2DM) patients suffering from cerebral infarction (CI) and const
Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazone
Background: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) have cardiovascular (CV) benefits, particularly in reducing the risk of heart failure (HF). Pioglitazone (Pio) has shown potential in de
Depression and type 2 diabetes risk: a Mendelian randomization study
Background: Extensive observational evidence has suggested an association between depression and type 2 diabetes (T2D). However, the causal relationships between these two diseases require further inv
Diabetes Insipidus (Hindi) : Internal Medicine
Follow on Instagram:- https://www.instagram.com/drgbhanuprakash Join Our Telegram ...
USMLE® Step 2 Obstetrics & Gynecology: Gestational Diabetes
Preview and share samples from Kaplan Medical's fast-paced, comprehensive USMLE® Step 2 review program - free. Our video ...
Endocrine Pharmacology (Ar) - 02 - Diabetes mellitus - Part 2- Oral antidiabetic drugs
Chapter 09: Endocrine Pharmacology - Lecture 02 Google Play link to Android App: ...